Cargando…

Development of Personalized Therapeutic Strategies by Targeting Actionable Vulnerabilities in Metastatic and Chemotherapy-Resistant Breast Cancer PDXs

Human breast cancer is characterized by a high degree of inter-patients heterogeneity in terms of histology, genomic alterations, gene expression patterns, and metastatic behavior, which deeply influences individual prognosis and treatment response. The main cause of mortality in breast cancer is th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Punzi, Simona, Meliksetian, Marine, Riva, Laura, Marocchi, Federica, Pruneri, Giancarlo, Criscitiello, Carmen, Orsi, Franco, Spaggiari, Lorenzo, Casiraghi, Monica, Della Vigna, Paolo, Luzi, Lucilla, Curigliano, Giuseppe, Pelicci, Pier Giuseppe, Lanfrancone, Luisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627522/ https://www.ncbi.nlm.nih.gov/pubmed/31216647 http://dx.doi.org/10.3390/cells8060605

Ejemplares similares

RNAi screens identify CHD4 as an essential gene in breast cancer growth
por: D'Alesio, Carolina, et al.
Publicado: (2016)

WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells
por: Punzi, Simona, et al.
Publicado: (2019)

Genomics of Acute Myeloid Leukemia: The Next Generation
por: Riva, Laura, et al.
Publicado: (2012)

Long non‐coding RNA TINCR suppresses metastatic melanoma dissemination by preventing ATF4 translation
por: Melixetian, Marine, et al.
Publicado: (2021)

Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process
por: Melixetian, Marine, et al.
Publicado: (2022)

Cerebro: interactive visualization of scRNA-seq data
por: Hillje, Roman, et al.
Publicado: (2020)

XenoCell: classification of cellular barcodes in single cell experiments from xenograft samples
por: Cheloni, Stefano, et al.
Publicado: (2021)

A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data
por: Melloni, Giorgio E. M., et al.
Publicado: (2017)

ShcD Binds DOCK4, Promotes Ameboid Motility and Metastasis Dissemination, Predicting Poor Prognosis in Melanoma
por: Aladowicz, Ewa, et al.
Publicado: (2020)

p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value
por: Santoro, Angela, et al.
Publicado: (2019)

Modeling cell proliferation in human acute myeloid leukemia xenografts
por: Nobile, Marco S, et al.
Publicado: (2019)

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
por: Choi, Yunsik, et al.
Publicado: (2018)

Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics
por: Guilhamon, Paul, et al.
Publicado: (2014)

Highlights from the 14(th) St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer
por: Esposito, Angela, et al.
Publicado: (2015)

Antibody–drug conjugates in solid tumors: a look into novel targets
por: Criscitiello, Carmen, et al.
Publicado: (2021)

Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines
por: Woo, Xing Yi, et al.
Publicado: (2019)

Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse
por: du Manoir, Stanislas, et al.
Publicado: (2013)

Pyridoxal phosphate synthases PdxS/PdxT are required for Actinobacillus pleuropneumoniae viability, stress tolerance and virulence
por: Xie, Fang, et al.
Publicado: (2017)

Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXs
por: Boyd, David C., et al.
Publicado: (2023)

Genome-wide mapping of human DNA-replication origins: Levels of transcription at ORC1 sites regulate origin selection and replication timing
por: Dellino, Gaetano Ivan, et al.
Publicado: (2013)

Establishment and Characterization of Patient-Derived Xenografts (PDXs) of Different Histology from Malignant Pleural Mesothelioma Patients
por: Affatato, Roberta, et al.
Publicado: (2020)

Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets
por: Lammers, Philip, et al.
Publicado: (2014)

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date
por: Criscitiello, Carmen, et al.
Publicado: (2018)

Toward precision medicine in inflammatory breast cancer
por: Viale, Giulia, et al.
Publicado: (2019)

Epigenomic profiling of archived FFPE tissues by enhanced PAT-ChIP (EPAT-ChIP) technology
por: Amatori, Stefano, et al.
Publicado: (2018)

Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”
por: Gelao, Lucia, et al.
Publicado: (2014)

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
por: Marra, Antonio, et al.
Publicado: (2020)

Time makes histone H3 modifications drift in mouse liver
por: Hillje, Roman, et al.
Publicado: (2022)

Mutations targeting the coagulation pathway are enriched in brain metastases
por: Richichi, Cristina, et al.
Publicado: (2017)

Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?
por: Curigliano, Giuseppe, et al.
Publicado: (2013)

AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets
por: Gardini, Alessandro, et al.
Publicado: (2008)

PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative
por: Ascione, Liliana, et al.
Publicado: (2022)

Predicting Response to Antibody Drug Conjugates: A Focus on Antigens’ Targetability
por: Ascione, Liliana, et al.
Publicado: (2023)

Correlative Multi-Modal Microscopy: A Novel Pipeline for Optimizing Fluorescence Microscopy Resolutions in Biological Applications
por: Pelicci, Simone, et al.
Publicado: (2023)

Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
por: Reddy, Tejaswini P., et al.
Publicado: (2020)

Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies
por: Mendogni, Paolo, et al.
Publicado: (2022)

Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging
por: Gambino, Valentina, et al.
Publicado: (2013)

Is PML a Tumor Suppressor?
por: Mazza, Massimiliano, et al.
Publicado: (2013)

PREP1 tumor suppressor protects the late-replicating DNA by controlling its replication timing and symmetry
por: Palmigiano, Angela, et al.
Publicado: (2018)

Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation
por: Zuco, Valentina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c2imvlmv9m8blfejibfns78n56